ezanga Logo
Home Our News About Us Contact Us Partners Cash Giveaway   Advertise Here
Search 
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Ariad Pharmaceuticals, Inc. (NQ: ARIA)
16.62 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Ariad Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Ariad Pharmaceuticals Earnings Hindsight: Down 5.0% in Last 13 Days (ARIA)
May 20, 2013
from Comtex SmarTrend® News Briefs
Ariad Pharmaceuticals Falling Today on Above-Average Volume (ARIA)
May 16, 2013
from Comtex SmarTrend® News Briefs
Mixed Open As Jobless Claims Rise
May 16, 2013
The markets opened mixed with the Dow slipping 22 points to 15,253 while Nasdaq added 2 points to 3474. First time applications for unemployment benefits rose after falling to five year low last week. Read More
category Market News
from MarketMinute.com Market Updates
Benzinga's Top Pre-Market Losers
May 16, 2013
Ariad Pharmaceuticals Inc. (NASDAQ: ARIA ) dipped 2.16% to $16.75 in the pre-market session.Ariad Pharmaceuticals' PEG Ratio is -1.03. Alexza Pharmaceuticals Inc. (NASDAQ: ALXA ) shares fell 2.16% to... Read More
category Benzinga , Benzinga's Top Pre/Market Losers , WMT , and 8 more.
from Latest Articles from Benzinga.com
Ariad Pharmaceuticals (ARIA) falls on PEG ratio
May 16, 2013
Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) dipped 3.9% to $16.45. Ariad’s PEG Ratio is -1.03. Share volume was 8.3 million, dwarfing an all-day average of 2.8 million Read More
from BAYSTREET RSS FEED
New cancer tools allow patients to reconsider chemo
May 15, 2013
LOS ANGELES, May 15 (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh... Read More
category companyNews
from Reuters: Company News
Loeb's Third Point LLC Enters Anadarko (APC), NXP Semi (NXPI), Tiffany & Co. (TIF); Exits Herbalife (HLF), Morgan Stanley (MS)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8344583 for the full story. Read More
from StreetInsider.com News Articles
5 Biotechnology Stocks to Buy Now
May 15, 2013
 Read More
category NASDAQ:INSM , NASDAQ:ARIA , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
KERX, ARIA, PDLI added to BioStock Watch List at GSR
May 14, 2013
from ACCESSWIRE
5 Biotechnology Stocks to Buy Now
May 08, 2013
 Read More
category NASDAQ:INSM , NASDAQ:ARIA , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
Ariad Pharma (ARIA) Posts Narrower than Expected Q1 Loss
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8310665 for the full story. Read More
from StreetInsider.com News Articles
Trading Radar for 05/07: Electronic Arts (EA), DirecTV (DTV), Fossil (FOSL), McKesson (MCK) Report
May 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8309221 for the full story. Read More
from StreetInsider.com News Articles
5 Biotechnology Stocks to Buy Now
May 01, 2013
 Read More
category NASDAQ:INSM , NASDAQ:ARIA , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
Snatch ARIA 8.0% Lower Than Its Secondary?
April 29, 2013
Looking back to 95 days ago, ARIAD Pharmaceuticals, Inc. (ARIA) priced a 15,307,000 share secondary stock offering at $19.60 per share. Read More
category Stocks
from Market News Video
6 Biotechnology Stocks to Buy Now
April 24, 2013
 Read More
category NASDAQ:INSM , NASDAQ:ARIA , Stocks to Buy , and 4 more.
from InvestorPlace - Latest Headlines
5 Biotechnology Stocks to Buy Now
April 17, 2013
 Read More
category NASDAQ:INSM , NASDAQ:ARIA , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
Jefferies Maintains Bullish View on ARIAD Pharmaceuticals (ARIA)
April 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8249582 for the full story. Read More
from StreetInsider.com News Articles
5 Biotechnology Stocks to Buy Now
April 10, 2013
 Read More
category NASDAQ:INSM , NASDAQ:ARIA , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
ARIAD Presents New Preclinical Data Showing Ponatinib Overcomes Resistant Mutations in KIT, an Oncogenic Driver of Gastrointestinal Stromal Tumors
April 09, 2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA ) today announced the presentation of preclinical data on ponatinib (Iclusig™) at the American Association for Cancer Research (AACR) Annual Meeting 2013, in... Read More
category Benzinga , News , FDA , and 1 more.
from Latest Articles from Benzinga.com
Streetinsider.com Pre-Market Movers 04/04: (ALU) (PSDV) (NAVB) Higher; (MACK) (CPWR) (LSE) Lower
April 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8233428 for the full story. Read More
from StreetInsider.com News Articles
ARIAD Pharma (ARIA) Updates on Iclusig Following Launch
April 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8232839 for the full story. Read More
from StreetInsider.com News Articles
Shares of Ariad Pharmaceuticals Are Down on Strong Volume (ARIA)
April 03, 2013
from Comtex SmarTrend® News Briefs
5 Biotechnology Stocks to Buy Now
April 03, 2013
 Read More
category NASDAQ:INSM , NASDAQ:ARIA , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
Ariad Pharmaceuticals (ARIA) - Trading Recap
April 03, 2013
NEW YORK (AVAFIN) -- Financial institutions traded 35 block trades on shares of Ariad ... Read More
from AVAFIN
3 Under-the-Radar Tech Stocks: Top Portfolio Manager
April 01, 2013
Three technology laggards have strong potential upside, Zack Safran of Ivy Science & Technology Fund says. Read More
category tvfmwebex , Fast Money Halftime Report , Aspen Technology Inc , and 12 more.
from CNBC.com News
Jefferies Likes Early Iclusig Sales Data for ARIAD Pharmaceuticals (ARIA)
April 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8220629 for the full story. Read More
from StreetInsider.com News Articles
Biotech Movers: Analyst Upgrades Lift Puma
April 01, 2013
 Read More
category NASDAQ:IDIX , NASDAQ:ARIA , NASDAQ:ARRY , and 3 more.
from InvestorPlace - Latest Headlines
UPDATE: Goldman Sachs Initiates Ariad Pharmaceuticals with Neutral Rating on Fair Valuation
March 28, 2013
In a report published Thursday, Goldman Sachs analyst Terence Flynn initiated coverage on Ariad Pharmaceuticals (NASDAQ: ARIA ) with a Neutral rating and $20.00 price target. In the report, Flynn... Read More
category Goldman Sachs , Benzinga , Initiation , and 3 more.
from Latest Articles from Benzinga.com
Goldman Sachs Starts ARIAD Pharmaceuticals (ARIA) at Neutral
March 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8216864 for the full story. Read More
from StreetInsider.com News Articles
ARIAD Pharmaceuticals, Inc. Larger Than S&P 500 Component Dean Foods Co.
March 27, 2013
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component ARIAD Pharmaceuticals, Inc. (ARIA) was identified as having a larger market cap than the smaller end of the... Read More
category Stocks
from Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
© Copyright 2003 - eZanga.com, Inc.All Rights Reserved.